Investigating the Experiences of Individuals With Gastric Cancer Participating in Clinical Trials
NCT05699278 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-06-12
Summary
This study is observational, meaning that it does not include any interventions or new treatments. As a result, there may not be an immediate benefit for the patient with gastric cancer.
However, the data collected from this trial can contribute to a better understanding of the factors that affect withdrawal and enrolment rates in gastric cancer clinical trials, and may ultimately lead to improved patient outcomes in the future.
Conditions
Sponsors & Collaborators
-
Power Life Sciences Inc.
lead INDUSTRY
Principal Investigators
-
Michael B Gill · Power Life Sciences Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-29
- Primary Completion
- 2025-02-28
- Completion
- 2026-02-28
More Related Trials
-
The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach Cancer
NCT05000554 ·Status: RECRUITING ·Phase: PHASE2
-
Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer
NCT01573468 ·Status: UNKNOWN ·Phase: PHASE2
-
Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer
NCT05497739 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer
NCT00003172 ·Status: COMPLETED ·Phase: PHASE2
-
Resistance to Immunotherapy in Gastric Cancer
NCT03614013 ·Status: UNKNOWN
-
Study of Weekly DCF to Treat Advanced Gastric Cancer
NCT00568971 ·Status: TERMINATED ·Phase: PHASE2
-
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
NCT04931420 ·Status: WITHDRAWN ·Phase: PHASE2
-
Assessing Quality of Life of Patients With Stomach Cancer
NCT00020826 ·Status: COMPLETED
-
A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer
NCT05165264 ·Status: ACTIVE_NOT_RECRUITING
-
A Safety and Efficacy Study in Patients With Gastric Cancer
NCT00400179 ·Status: COMPLETED ·Phase: PHASE3
-
Transcriptomic Signatures in Gastric Adenocarcinoma
NCT05319392 ·Status: UNKNOWN
-
A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction
NCT02202759 ·Status: TERMINATED ·Phase: PHASE2
-
Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
NCT00103103 ·Status: TERMINATED ·Phase: PHASE2
-
Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial
NCT06943794 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Metronomic Capecitabine in Stage III Gastric Cancer
NCT06313567 ·Status: RECRUITING ·Phase: PHASE3
-
Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer
NCT03042169 ·Status: TERMINATED ·Phase: PHASE3
-
Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer
NCT03819088 ·Status: COMPLETED ·Phase: NA
-
Gastric Cancer Survival Without Chemotherapy
NCT05125614 ·Status: COMPLETED
-
Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy
NCT06202781 ·Status: RECRUITING
-
Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer
NCT04487717 ·Status: ACTIVE_NOT_RECRUITING
-
Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment
NCT02674373 ·Status: UNKNOWN
-
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
NCT00002615 ·Status: COMPLETED ·Phase: PHASE3
-
Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer
NCT03575637 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancer
NCT04258657 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer
NCT01305993 ·Status: UNKNOWN ·Phase: PHASE2